Skip to main content
. 2015 Mar 27;11(3):e1004750. doi: 10.1371/journal.ppat.1004750

Fig 8. Reduced neurovirulence of NS5-M19A—mutated JEV in challenged mice.

Fig 8

(A) Survival in C57BL/6 mice infected with 0.2, 2 or 20 plaque-forming units (PFU) of JEV-WT or JEV-NS5-M19A by an intracerebral (i.c.) injection. The animal number (n) and survival rate for each group are shown. (B-D) RT-qPCR of relative JEV RNA (B), IL-6 (C), and TNF-α (D) mRNA levels in brain tissues of mice inoculated with JEV-WT or JEV-NS5-M19A (20 PFU) (n = 3). Data are mean±SD.*P < 0.05.